| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 529 | 6.904 | 2.994 | 2.955 | 211 | 413 | 16.065 | 30.336 | 31.211 | 33.189 |
| Total Income - EUR | 2.250 | 9.965 | 6.003 | 5.909 | 3.108 | 3.255 | 18.844 | 33.123 | 33.083 | 33.189 |
| Total Expenses - EUR | 2.179 | 9.809 | 5.890 | 5.816 | 2.925 | 2.852 | 7.151 | 9.140 | 11.046 | 10.448 |
| Gross Profit/Loss - EUR | 71 | 156 | 113 | 93 | 183 | 403 | 11.693 | 23.984 | 22.037 | 22.741 |
| Net Profit/Loss - EUR | 55 | 4 | 23 | 4 | 177 | 391 | 11.532 | 23.546 | 21.724 | 21.745 |
| Employees | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dermogenesis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.690 | 22.366 | 18.978 | 15.676 | 12.475 | 9.397 | 6.410 | 3.642 | 1.315 | 0 |
| Current Assets | 4.977 | 290 | 116 | 480 | 313 | 704 | 13.161 | 35.068 | 25.275 | 25.997 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.516 | 18.516 |
| Cash | 4.977 | 290 | 116 | 480 | 313 | 704 | 13.161 | 35.068 | 11.758 | 7.481 |
| Shareholders Funds | 100 | 103 | 125 | 127 | 301 | 686 | 12.203 | 35.787 | 21.765 | 21.786 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.836 | 22.553 | 1.896 | 2.223 | 1.845 | 1.816 | 2.717 | 1.046 | 4.825 | 4.211 |
| Income in Advance | 23.731 | 20.428 | 17.073 | 13.806 | 10.642 | 7.598 | 4.650 | 1.877 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermogenesis Srl